Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
    • Lynch Syndrome
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal Care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events
    • Jeannie Ferris Recognition Award

Leukaemia

leukaemia-mm cancer-types/leukaemia/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Health professionals
Loading...

Health professionals

  • Printer-friendly version
  • A|A

Optimal care pathway for people leukaemia

The Optimal Care Pathways outline consistent, safe, high-quality and evidence-based care for people with cancer. Relevant to every step along the cancer continuum, the Optimal Care Pathways aim to improve patient outcomes for people affected by cancer, and ensure that Australians diagnosed with cancer receive the best care irrespective of where they live or receive cancer treatment.

Key principles for optimal cancer care are set out for each step of the patient journey from prevention through to survivorship and end of life care, and optimal timeframes within which tests or procedures should be completed.

National endorsement

The Optimal Care Pathways are endorsed by Cancer Australia, all states and territories and Cancer Council Australia.

For health professionals and health services

The Optimal Care Pathways are available in their full version or as a Quick Reference Guide (summary version):

  • Optimal care pathways for children, adolescents and young adults with acute leukaemia
  • Optimal care pathways for children, adolescents and young adults with acute leukaemia: Quick reference guide
     
  • Optimal care pathway for people with acute myeloid leukaemia
  • Optimal care pathway for people with acute myeloid leukaemia: Quick reference guide
     
  • Optimal care pathway for people with chronic lymphocytic leukaemia
  • Optimal care pathway for people with chronic lymphocytic leukaemia: Quick reference guide
     
  • Optimal care pathway for people with chronic myeloid leukaemia
  • Optimal care pathway for people with chronic myeloid leukaemia: Quick reference guide

For people affected by cancer 

Consumer versions of the Optimal Care Pathways are available to help patients and their families and carers to understand the optimal cancer care that should be provided from diagnosis, through to treatment and beyond. They are available in multiple languages.

The Guides to Best Cancer Care include optimal timeframes within which tests or procedures should be completed; prompt lists to support patients to understand what might happen at each step of their cancer experience and to consider what questions to ask; and provide information to help patients and carers communicate with health professionals.

  • Acute leukaemia in children, adolescents and young adults: Your guide to best cancer care
  • Acute myeloid leukaemia: Your guide to best cancer care
  • Chronic lymphocytic leukaemia: Your guide to best cancer care
  • Chronic myeloid leukaemia: Your guide to best cancer care

Optimal care pathway for Aboriginal and Torres Strait Islander people with cancer

The Optimal care pathway for Aboriginal and Torres Strait Islander people with cancer has been developed with the aim of reducing disparities and improving outcomes and experiences for Aboriginal and Torres Strait Islander people with cancer. The Optimal Care Pathway provides guidance to health practitioners and service planners on optimal care for Aboriginal and Torres Strait Islander people with cancer, across the cancer continuum. It complements the best practice information provided in the cancer-specific pathways.

The Optimal care pathway for Aboriginal and Torres Strait Islander people with cancer is available in a full version and Quick Reference Guide (summary version).

For health professionals and health services

  • Optimal care pathway for Aboriginal and Torres Strait Islander people with cancer
  • Optimal care pathway for Aboriginal and Torres Strait Islander people with cancer: Quick Reference Guide

Resources for Aboriginal and Torres Strait Islander patients and families affected by cancer 

  • Our Mob and Cancer
  • Checking for cancer – what to expect
  • Cancer – what to expect

Clinical practice guidelines and other guidelines relating to leukaemia

•       National Health and Medical Research Council, Australian consensus guidelines for the management of neutropenic fever in adult cancer patients

•       American Society of Hematology, American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

•       National Comprehensive Cancer Network (US), Clinical Practice Guidelines in Oncology: Acute Lymphoblastic Leukemia, version 1.2021 (register for free to access these)

•       National Comprehensive Cancer Network (US), Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia, version 3.2021 (register for free to access these)

•       National Comprehensive Cancer Network (US), Clinical Practice Guidelines in Oncology: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, version 4.2021 (register for free to access these)

•       National Comprehensive Cancer Network (US),  Clinical Practice Guidelines in Oncology: Chronic Myeloid Leukemia, version 3.2021 (register for free to access these)

•       National Comprehensive Cancer Network (US), Clinical Practice Guidelines in Oncology: Hairy Cell Leukemia, version 2.2021 (register for free to access these)

•       European Society for Medical Oncology, Clinical Practice Guidelines – Acute Myeloid Leukaemia in Adult Patients

•       European Society for Medical Oncology, Acute Lymphoblastic Leukaemia: ESMO Clinical Practice Guidelines

•       European Society for Medical Oncology, Chronic Myeloid Leukemia: ESMO Clinical Practice Guidelines

•       European Society for Medical Oncology, Chronic Lymphocytic Leukaemia: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

•       European Society for Medical Oncology, Hairy Cell Leukaemia: ESMO Clinical Practice Guidelines

 

For more information about leukaemia, diagnosis and treatment

See the National Cancer Institute’s (US) resources for health professionals:

•       Adult Acute Lymphoblastic Leukemia Treatment

•       Adult Acute Myeloid Leukemia Treatment

•       Chronic Lymphocytic Leukemia Treatment

•       Chronic Myelogenous Leukemia Treatment

•       Hairy Cell Leukemia Treatment.

When reading materials that are published in other countries, note that some of the information may not apply to Australian patients.

  • Last Updated
  • Relevant Links
updated: 29 March 2023 - 4:08pm
Leukaemia Foundation Australia
Cancer Council Australia, Leukaemia
Australasian Leukaemia & Lymphoma Group
Cancer Australian Children’s Cancer – Leukaemia
Australian Cancer Trials

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia